SCHEMBL1743583

SCHEMBL1743583

CCc1c(OC)cc2c(c1O)C(=O)CC1CCN(C)CC21

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.55
CDK4 P11802 6/20 0.36
CCND1 P24385 6/20 0.36
DRD2 P14416 1/20 0.34
DRD3 P35462 1/20 0.34
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
HTR2C P28335 1/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 1/20 0.32
QDPR P09417 1/20 0.32
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1743580 1.00 IDO1 (0.55) IDO1CDK4CCND1DRD2DRD3
SCHEMBL1743577 1.00 IDO1 (0.55) IDO1CDK4CCND1DRD2DRD3
SCHEMBL6558377 1.00 IDO1 (0.55) IDO1CDK4CCND1DRD2DRD3
Hydrochloric Acid SCHEMBL6556581 0.99 IDO1 (0.54) IDO1CDK4CCND1DRD2DRD3
Hydrochloric Acid SCHEMBL6556575 0.99 IDO1 (0.54) IDO1CDK4CCND1DRD2DRD3
Hydrochloric Acid SCHEMBL6556570 0.99 IDO1 (0.54) IDO1CDK4CCND1DRD2DRD3
SCHEMBL6556426 0.90 IDO1 (0.58) IDO1PDE4DPDCD1CD274ALDH1A1
SCHEMBL6556422 0.90 IDO1 (0.58) IDO1PDE4DPDCD1CD274ALDH1A1
SCHEMBL6556416 0.90 IDO1 (0.58) IDO1PDE4DPDCD1CD274ALDH1A1
SCHEMBL6556322 0.88 IDO1 (0.41) IDO1CDK4CCND1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958285-B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES HOFFMANN LA ROCHE (CH) 2004-01-07 EP claimed
US-9730945-B2 Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-08-15 US disclosed
US-20150126496-A1 DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-05-07 US disclosed
US-8940732-B2 Diagnosis of autism spectrum disorders and its treatment with an antagonist or inhibitor of the 5-HT2c receptor signaling pathway MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-01-27 US disclosed
WO-2012149472-A2 METHODS, COMPOSITIONS, AND KITS FOR TREATING AND PREVENTING NEUROLOGICAL CONDITIONS IGNITE INSTITUTE FOR INDIVIDUALIZED HEALTH (US) 2012-11-01 WO disclosed
EP-2387611-A1 DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS Massachusetts Institute of Technology (US) 2011-11-23 EP disclosed
US-8040693-B2 Universal expandable patch panel bracket PANDUIT CORP. (US) 2011-10-18 US disclosed
US-20100298304-A1 DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-11-25 US disclosed
WO-2010083044-A1 DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-07-22 WO disclosed
EP-0958285-B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES HOFFMANN LA ROCHE (CH) 2004-01-07 EP disclosed
US-6310208-B1 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines HOFFMANN-LA ROCHE INC. 2001-10-30 US disclosed